Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission.
Klyuchnikov E, Badbaran A, Massoud R, Fritzsche-Friedland U, Freiberger P, Ayuk F, Wolschke C, Bacher U, Kröger N. Klyuchnikov E, et al. Among authors: freiberger p. Transplant Cell Ther. 2022 Jul;28(7):374.e1-374.e9. doi: 10.1016/j.jtct.2022.04.009. Epub 2022 Apr 13. Transplant Cell Ther. 2022. PMID: 35429661 Free article.
Individualized busulfan dosing improves outcomes compared to fixed-dose administration in pre-transplant minimal residual disease-positive acute myeloid leukemia patients with intermediate-risk undergoing allogeneic stem cell transplantation in CR.
Klyuchnikov E, Langebrake C, Badbaran A, Dadkhah A, Massoud R, Freiberger P, Ayuk F, Janson D, Wolschke C, Bacher U, Kröger N. Klyuchnikov E, et al. Among authors: freiberger p. Eur J Haematol. 2023 Feb;110(2):188-197. doi: 10.1111/ejh.13893. Epub 2022 Dec 1. Eur J Haematol. 2023. PMID: 36335432 Free article.
Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR.
Klyuchnikov E, Badbaran A, Massoud R, Freiberger P, Wolschke C, Ayuk F, Fehse B, Bacher U, Kröger N. Klyuchnikov E, et al. Among authors: freiberger p. Leukemia. 2024 Feb;38(2):386-388. doi: 10.1038/s41375-024-02148-3. Epub 2024 Jan 23. Leukemia. 2024. PMID: 38263432 No abstract available.